Archwamety A.Ruangchira-urai R.Akewanlop C.Korphaisarn K.Mahidol University2023-06-182023-06-182022-09-01Thoracic Cancer Vol.13 No.17 (2022) , 2539-254117597706https://repository.li.mahidol.ac.th/handle/20.500.14594/85600Here, we report a case of metastatic Epstein–Barr virus (EBV)-related primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) in a young, nonsmoking female who responded well to treatment with two types of immune checkpoint inhibitors (ICIs). This is the first case report of a favorable outcome to ICIs in the late-line treatment of advanced PPLELC patients with programmed cell death-ligand 1 (PD-L1) expression.MedicineArticleSCOPUS10.1111/1759-7714.145802-s2.0-851339034481759771435830974